Structure Therapeutics Inc. SEC filings GPCR

Structure Therapeutics Inc. has 271 filings in SEC EDGAR's recent list, going back to Oct 21, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Structure Therapeutics Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
4 Insider transaction Sep 22, 2026 Sep 18, 2026
144 Notice of proposed sale Sep 21, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 8, 2026
4 Insider transaction Sep 2, 2026 Sep 1, 2026
4 Insider transaction Aug 19, 2026 Aug 18, 2026
4 Insider transaction Aug 7, 2026 Aug 6, 2026
3 Initial insider ownership Aug 7, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction Aug 5, 2026 Aug 4, 2026
4 Insider transaction Jul 24, 2026 Jul 22, 2026
4 Insider transaction Jul 15, 2026 Jul 14, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Material agreement, Results of operations, Other events
May 7, 2026 May 7, 2026
424B5 Prospectus supplement May 7, 2026 —
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 23, 2026 Jun 17, 2026
4 Insider transaction Apr 23, 2026 Apr 15, 2026
3 Initial insider ownership Apr 23, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 15, 2026 Apr 15, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
4 Insider transaction Mar 23, 2026 Mar 19, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 16, 2026 Mar 16, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
8-K Current report
Material agreement
Jan 5, 2026 Dec 30, 2025
8-K Current report
Other events
Dec 10, 2025 Dec 9, 2025
424B5 Prospectus supplement Dec 10, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
424B5 Prospectus supplement Dec 8, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2025 Dec 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Aug 20, 2025 Jul 1, 2025
4 Insider transaction Aug 20, 2025 Jul 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
S-3ASR Automatic shelf registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
4 Insider transaction Aug 1, 2025 Jul 30, 2025
4 Insider transaction Jul 3, 2025 Mar 1, 2025
4 Insider transaction Jul 3, 2025 Mar 1, 2025
4 Insider transaction Jul 3, 2025 Mar 1, 2025
4 Insider transaction Jul 3, 2025 Mar 1, 2025
4 Insider transaction Jul 3, 2025 Mar 1, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 23, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 24, 2025 Jun 23, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 10, 2025 Feb 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 13, 2025 —
8-K Current report
Regulation FD disclosure
Dec 17, 2024 Dec 17, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
SC 13G Ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
4 Insider transaction Sep 20, 2024 Sep 18, 2024
3 Initial insider ownership Sep 20, 2024 Sep 18, 2024
4 Insider transaction Sep 20, 2024 Sep 18, 2024
3 Initial insider ownership Sep 20, 2024 Sep 18, 2024
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 17, 2024 Sep 12, 2024
4 Insider transaction Aug 28, 2024 Aug 26, 2024
3 Initial insider ownership Aug 28, 2024 Aug 26, 2024
8-K Current report
Officer or director change
Aug 27, 2024 Aug 24, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results, Other events
Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
3 Initial insider ownership Jun 13, 2024 Jun 6, 2024
4 Insider transaction Jun 12, 2024 Jun 10, 2024
144 Notice of proposed sale Jun 10, 2024 —
424B4 Prospectus Jun 6, 2024 —
EFFECT Filing Jun 5, 2024 —
S-1MEF Filing Jun 5, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
UPLOAD Letter from the SEC Jun 4, 2024 —
CORRESP Letter to the SEC Jun 3, 2024 —
CORRESP Letter to the SEC Jun 3, 2024 —
8-K Current report
Other events
Jun 3, 2024 Jun 3, 2024
144 Notice of proposed sale Jun 3, 2024 —
S-1 Registration statement Jun 3, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2024 Jun 3, 2024
CORRESP Letter to the SEC May 31, 2024 —
UPLOAD Letter from the SEC May 31, 2024 —
SC 13G Ownership over 5% (passive) May 30, 2024 —
CORRESP Letter to the SEC May 24, 2024 —
UPLOAD Letter from the SEC May 22, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 25, 2024 Jun 25, 2024
4 Insider transaction Apr 19, 2024 Apr 17, 2024
4/A Filing Mar 20, 2024 Mar 15, 2024
4/A Filing Mar 20, 2024 Mar 15, 2024
4/A Filing Mar 20, 2024 Mar 15, 2024
4/A Filing Mar 20, 2024 Mar 15, 2024
4/A Filing Mar 20, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 18, 2024 Mar 14, 2024
S-8 Employee stock plan registration Mar 8, 2024 —
10-K Annual report Mar 8, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 8, 2024 Mar 8, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
4 Insider transaction Dec 27, 2023 Dec 22, 2023
SC 13G/A Amended ownership over 5% (passive) Dec 20, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Dec 18, 2023 Dec 18, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
EFFECT Filing Nov 29, 2023 —
CORRESP Letter to the SEC Nov 27, 2023 —
UPLOAD Letter from the SEC Nov 24, 2023 —
UPLOAD Letter from the SEC Nov 24, 2023 —
DRS Filing Nov 20, 2023 —
S-1 Registration statement Nov 17, 2023 —
10-Q Quarterly report Nov 17, 2023 Sep 30, 2023
10-Q/A Amended quarterly report Nov 17, 2023 Jun 30, 2023
10-Q/A Amended quarterly report Nov 16, 2023 Jun 30, 2023
NT 10-Q Filing Nov 14, 2023 Sep 30, 2023
8-K Current report
Material agreement, Results of operations
Nov 14, 2023 Nov 7, 2023
4 Insider transaction Oct 23, 2023 Oct 18, 2023
SC 13G/A Amended ownership over 5% (passive) Oct 13, 2023 —
3 Initial insider ownership Oct 12, 2023 Oct 2, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 29, 2023 Sep 29, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GPCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1888886
Former names
ShouTi Inc. (until May 13, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.